← Back to All Filings

Jazz Pharmaceuticals Director Norbert G. Riedel Disposes Shares for Tax Obligations

Low SignificanceSeptember 2, 2026 at 9:38:32 PM UTC

Jazz Pharmaceuticals plc

$JAZZ4CIK: 0001232524

Subscribe to track JAZZ

Premium users can add ticker alerts and receive realtime notification updates.

Filing Summary

Jazz Pharmaceuticals plc ($JAZZ) – Form 4 Insider Filing Insider: Norbert G. Riedel (Director) Type: Disposition (Tax Withholding - Code F) Shares Transacted: 1,706 ordinary shares Total Value: ~$411,856.90 Shares Held Post-Transaction: 6,923 direct (plus 10,630 indirect via Trust) Significance: Low (Routine disposition to satisfy tax obligations on RSU vesting)

Comprehensive Analysis

Executive Summary

On September 2, 2026, Jazz Pharmaceuticals plc ($JAZZ) director Norbert G. Riedel filed a Form 4 reporting dispositions of ordinary shares on August 31, 2026, totaling 1,706 shares valued at approximately $411,856.90.

Transaction Breakdown

  • Security: Ordinary Shares
  • Transaction Code: F (Payment of exercise price or tax liability by delivering or withholding securities)
  • Transaction Details:
    • Tranche 1: 14 shares disposed at $244.6443 per share ($3,425.02)
    • Tranche 2: 1,692 shares disposed at $241.3900 per share ($408,431.88)
    • Total Disposed: 1,706 shares for an aggregate value of $411,856.90
  • Post-Transaction Holdings:
    • Direct Ownership: 6,923 ordinary shares
    • Indirect Ownership: 10,630 ordinary shares held via Trust

Strategic & Market Implications

  • Purpose: According to the footnotes, these shares were withheld/sold solely to satisfy tax withholding obligations triggered by the vesting of previously granted restricted stock units (RSUs).
  • Market Sentiment: Low informational value for open-market sentiment, as mandatory or automated tax-withholding dispositions do not reflect discretionary insider selling.
Topics:#JAZZ#JazzPharmaceuticals#InsiderTrading#Form4#Biotech#StockMarket

Get Real-Time Alerts

Join our community to receive instant notifications when high-significance filings are published

Important Disclaimer

This content is AI-generated from public SEC filings and may contain errors. It is for informational and educational purposes only and is not investment, legal, or tax advice.

The Filing Fool is not a registered investment adviser, broker-dealer, or financial planner. Nothing here is a recommendation or solicitation to buy, sell, or hold any security.

Always do your own due diligence and consult a licensed professional.